AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BETASHARES GLOBAL HEALTHCARE

9.000

+0.0300.33%

Volume:35.71K

Turnover:320.87K

Market Cap:- -

PE:- -

High:9.030

Open:9.030

Low:8.970

Close:8.970

52wk High:9.100

52wk Low:7.242

Shares:- -

Float Shares:19.86M

Volume Ratio:1.11

T/O Rate:0.18%

Dividend:0.03

Dividend Rate:0.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Indicative 2026 Distributions Calendar

Units on Issue Disclosure - December 2025

Bright Minds Biosciences Says Phase 2 Trial Results of BMB-101 Show 'Robust' Reduction in Seizure

MT Newswires Live

Distribution Timetable

Units on Issue Disclosure - November 2025

Annual Report

Bright Minds Biosciences Enters Deal for $100 Million At-The-Market Offering

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/DRUG.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DRUG.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DRUG.AU\",,,,,undefined,":{"symbol":"DRUG.AU","market":"AU","secType":"STK","nameCN":"BETASHARES GLOBAL HEALTHCARE","latestPrice":9,"timestamp":1772082720000,"preClose":8.97,"halted":0,"volume":35710,"delay":0,"changeRate":0.003344481605351099,"nameEN":"BETASHARES GLOBAL HEALTHCARE","floatShares":19855770,"shares":0,"eps":0,"marketStatus":"Closed","change":0.03,"latestTime":"02-26 16:12:00 AEDT","open":9.03,"high":9.03,"low":8.97,"amount":320872,"amplitude":0.006689,"askPrice":9.15,"askSize":652,"bidPrice":8.96,"bidSize":60,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1772146800000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":8.97,"sharesOutstanding":19855770,"nav":9.027256,"aum":179243118,"dividendRate":0.003822,"bidAskSpread":0,"openAndCloseTimeList":[[1772060400000,1772082000000]],"volumeRatio":1.108043,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DRUG.AU\",,,,,undefined,":{"symbol":"DRUG.AU","floatShares":19855770,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.108043,"shares":0,"dividePrice":0.034394,"high":9.03,"amplitude":0.006689,"preClose":8.97,"low":8.97,"week52Low":7.242,"pbRate":"--","week52High":9.1,"institutionHeld":0,"latestPrice":9,"committee":-0.831461,"eps":0,"divideRate":0.003822,"volume":35710,"delay":0,"ttmEps":0,"open":9.03,"prevYearClose":8.756,"prevWeekClose":9.07,"prevMonthClose":8.73,"prevQuarterClose":8.756,"fiveDayClose":9.05,"twentyDayClose":8.76,"sixtyDayClose":8.805},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DRUG.AU\",params:#limit:5,,,undefined,":[{"date":"2026-01-02","symbol":"DRUG.AU","amount":0.03439369,"announcedDate":"2025-12-30","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-01-05","name":"BETASHARES GLOBAL HEALTHCARE","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-19","payableDate":"2026-01-05","currency":"AUD","dateTimestamp":1767272400000,"payDate":"2026-01-19"},{"date":"2025-01-02","symbol":"DRUG.AU","amount":0.027266,"announcedDate":"2024-12-30","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-01-03","name":"BETASHARES GLOBAL HEALTHCARE","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-17","payableDate":"2025-01-03","currency":"AUD","dateTimestamp":1735736400000,"payDate":"2025-01-17"},{"date":"2024-07-01","symbol":"DRUG.AU","amount":0.223016,"announcedDate":"2024-06-27","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-07-02","defaultRemindTime":1719792000000,"name":"BETASHARES GLOBAL HEALTHCARE","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-16","payableDate":"2024-07-02","currency":"AUD","dateTimestamp":1719756000000,"payDate":"2024-07-16"},{"date":"2024-01-02","symbol":"DRUG.AU","amount":0.0267117,"announcedDate":"2023-12-21","type":"dividend","market":"AU","newRecordDate":"2024-01-03","defaultRemindTime":1704150000000,"name":"BetaShares Global Healthcare Currency Hedged","recordDate":"2024-01-17","payableDate":"2024-01-03","currency":"AUD","dateTimestamp":1704114000000,"payDate":"2024-01-17"},{"market":"AU","date":"2023-01-03","symbol":"DRUG.AU","amount":0.0261979,"defaultRemindTime":1672700400000,"name":"BetaShares Global Healthcare Currency Hedged","recordDate":"2023-01-18","payableDate":"2023-01-04","currency":"AUD","type":"dividend","dateTimestamp":1672664400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DRUG.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2021-01-04","recordDate":"2021-01-05","paymentDate":"2021-01-19","value":0.0166015,"currency":"AUD"},{"executeDate":"2021-07-01","recordDate":"2021-07-02","paymentDate":"2021-07-16","value":0.3498407,"currency":"AUD"},{"executeDate":"2022-01-04","recordDate":"2022-01-05","paymentDate":"2022-01-19","value":0.0191881,"currency":"AUD"},{"executeDate":"2023-01-03","recordDate":"2023-01-04","paymentDate":"2023-01-18","value":0.0261979,"currency":"AUD"},{"executeDate":"2024-01-02","recordDate":"2024-01-03","paymentDate":"2024-01-17","value":0.0267117,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DRUG.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608307493","title":"Indicative 2026 Distributions Calendar","url":"https://stock-news.laohu8.com/highlight/detail?id=2608307493","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608307493?lang=en_us&edition=fundamental","pubTime":"2026-02-04 14:46","pubTimestamp":1770187577,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260204:nASX6bPwTC","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nASXbJF3TM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QRE.AU","USD.AU","GGOV.AU","GBND.AU","GEAR.AU","JNDQ.AU","AGVT.AU","AEBD.AU","DRUG.AU","CFLO.AU","GGAB.AU","QUS.AU","RBTZ.AU","BSUB.AU","HETH.AU","HNDQ.AU","HJPN.AU","AAA.AU","GGBL.AU","NDQ.AU","G200.AU","UMAX.AU","URNM.AU","A200.AU","MTUM.AU","HBRD.AU","HGBL.AU","DZZF.AU","30BB.AU","QOZ.AU","US10.AU","WBND.AU","BNKS.AU","WRLD.AU","HQUS.AU","BNDS.AU","IIND.AU","QPON.AU","FUEL.AU","GAME.AU","QNDQ.AU","HACK.AU","UTIP.AU","HCRD.AU","HQLT.AU","HEUR.AU","29BB.AU","ECRD.AU","GGFD.AU","TOLL.AU"],"gpt_icon":0},{"id":"2601421678","title":"Units on Issue Disclosure - December 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2601421678","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601421678?lang=en_us&edition=fundamental","pubTime":"2026-01-07 08:57","pubTimestamp":1767747422,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260107:nASX3SjCQn","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nASX53wms6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YMAX.AU","DGGF.AU","QBTC.AU","AQLT.AU","CFLO.AU","MTUM.AU","HACK.AU","HEUR.AU","GGAB.AU","28BB.AU","FUEL.AU","MNRS.AU","QRE.AU","ATEC.AU","SMLL.AU","QUS.AU","BSUB.AU","HCRD.AU","H100.AU","TOLL.AU","DHHF.AU","DRIV.AU","HBRD.AU","MMKT.AU","BEAR.AU","BBAB.AU","QFN.AU","ERTH.AU","CRYP.AU","DRUG.AU","UMAX.AU","AAA.AU","QAU.AU","JNDQ.AU","QETH.AU","QLTY.AU","QMAX.AU","BHYB.AU","DBBF.AU","QNDQ.AU","AUDS.AU","HETH.AU","WBND.AU","AEBD.AU","ARMR.AU","QOZ.AU","EX20.AU","F100.AU","CLDD.AU","QPON.AU"],"gpt_icon":0},{"id":"2601890818","title":"Bright Minds Biosciences Says Phase 2 Trial Results of BMB-101 Show 'Robust' Reduction in Seizure","url":"https://stock-news.laohu8.com/highlight/detail?id=2601890818","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601890818?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:20","pubTimestamp":1767705644,"startTime":"0","endTime":"0","summary":"Bright Minds Biosciences  said Tuesday its phase 2 study of BMB-101, to treat absence seizures and developmental and encephalopathic epilepsies, met the primary efficacy endpoint by showing a \"robust\" seizure reduction with a \"favorable safety and tolerability\" profile.The trial enrolled a total of 24 participants and had a four-week baseline, four-week titration and maintenance period.The company said the patients demonstrated a 73% median reduction in the number of absence seizure in the absence seizure group. It was also found to be \"generally well tolerated\" and there were no treatment-related serious adverse effects seen.Bright Minds also said it has started preparations for global registrational trials in both absence seizures and developmental and encephalopathic epilepsies patients.Shares of the company were up 28% in recent Tuesday premarket activity.Price: 102.44, Change: +22.43, Percent Change: +28.03","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DRUG.AU","BK4139","DRUG"],"gpt_icon":0},{"id":"2593610064","title":"Distribution Timetable","url":"https://stock-news.laohu8.com/highlight/detail?id=2593610064","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593610064?lang=en_us&edition=fundamental","pubTime":"2025-12-23 14:13","pubTimestamp":1766470434,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251223:nASX8GQh1G","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nASX4C9KnD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["G200.AU","IIND.AU","YMAX.AU","HBRD.AU","UMAX.AU","AUST.AU","QNDQ.AU","EX20.AU","DZZF.AU","HCRD.AU","QMAX.AU","QFN.AU","A200.AU","JNDQ.AU","CRYP.AU","WBND.AU","H100.AU","QPON.AU","SMLL.AU","QLTY.AU","29BB.AU","TOLL.AU","GNDQ.AU","F100.AU","EXUS.AU","BHYB.AU","ATEC.AU","QUS.AU","HETH.AU","MNRS.AU","QRE.AU","28BB.AU","DRIV.AU","ASIA.AU","DBBF.AU","BGBL.AU","DHHF.AU","MMKT.AU","BNKS.AU","MTUM.AU","ETHI.AU","DRUG.AU","FOOD.AU","FUEL.AU","HEUR.AU","QOZ.AU","DGGF.AU","30BB.AU","FAIR.AU","HACK.AU"],"gpt_icon":0},{"id":"2588431077","title":"Units on Issue Disclosure - November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2588431077","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588431077?lang=en_us&edition=fundamental","pubTime":"2025-12-04 11:54","pubTimestamp":1764820495,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251204:nASXlTfs5","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nASX9B1STN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HBRD.AU","BBAB.AU","GGOV.AU","HETH.AU","CRYP.AU","WBND.AU","28BB.AU","HYLD.AU","QPON.AU","INCM.AU","ROYL.AU","YANK.AU","US10.AU","UMAX.AU","YMAX.AU","HVST.AU","ARMR.AU","BEMG.AU","IIND.AU","JNDQ.AU","BBOZ.AU","MTUM.AU","USD.AU","ERTH.AU","RBTZ.AU","DRUG.AU","CLDD.AU","AGVT.AU","QOZ.AU","BEAR.AU","BHYB.AU","QUS.AU","FUEL.AU","SMLL.AU","HCRD.AU","URNM.AU","H100.AU","BGBL.AU","FOOD.AU","QRE.AU","AQLT.AU","QMAX.AU","HACK.AU","ETHI.AU","CRED.AU","BBFD.AU","QNDQ.AU","TOLL.AU","DHHF.AU","DRIV.AU"],"gpt_icon":0},{"id":"2570065861","title":"Annual Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2570065861","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570065861?lang=en_us&edition=fundamental","pubTime":"2025-09-25 14:24","pubTimestamp":1758781467,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250925:nASX3qHqkS","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250925:nASX3vCwMy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNRS.AU","UMAX.AU","WRLD.AU","HJPN.AU","QMAX.AU","BNKS.AU","FUEL.AU","HEUR.AU","FOOD.AU","DRUG.AU"],"gpt_icon":0},{"id":"2565851555","title":"Bright Minds Biosciences Enters Deal for $100 Million At-The-Market Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2565851555","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565851555?lang=en_us&edition=fundamental","pubTime":"2025-09-05 16:46","pubTimestamp":1757062009,"startTime":"0","endTime":"0","summary":"Bright Minds Biosciences  said late Thursday it has entered an agreement with Piper Sandler and Cantor Fitzgerald to establish an at-the-market equity offering of up to $100 million.The program will run for three years, the company said.Bright Minds intends to use any funds raised for general corporate purposes, it said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DRUG.AU","BK4139","DRUG"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}]}}